PDB Short entry for 4DGC HEADER ISOMERASE/IMMUNOSUPPRESSANT 25-JAN-12 4DGC TITLE TRIMCYP CYCLOPHILIN DOMAIN FROM MACACA MULATTA: CYCLOSPORIN A COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIMCYP; COMPND 3 CHAIN: A, B, C, D, E; COMPND 4 FRAGMENT: CYCLOPHILIN DOMAIN (UNP RESIDUES 304-468); COMPND 5 SYNONYM: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CYCLOSPORIN A; COMPND 10 CHAIN: F, G, H, I, J; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MACACA MULATTA; SOURCE 3 ORGANISM_COMMON: RHESUS MACAQUE; SOURCE 4 ORGANISM_TAXID: 9544; SOURCE 5 GENE: TRIMCYP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: POPT; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 14 ORGANISM_TAXID: 29910 KEYWDS ANTI-VIRAL PROTEIN, ISOMERASE-IMMUNOSUPPRESSANT COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.E.C.CAINES,K.BICHEL,A.J.PRICE,W.A.MCEWAN,L.C.JAMES REVDAT 4 13-SEP-23 4DGC 1 LINK REVDAT 3 18-APR-12 4DGC 1 JRNL REVDAT 2 28-MAR-12 4DGC 1 JRNL REVDAT 1 08-FEB-12 4DGC 0 JRNL AUTH M.E.CAINES,K.BICHEL,A.J.PRICE,W.A.MCEWAN,G.J.TOWERS, JRNL AUTH 2 B.J.WILLETT,S.M.FREUND,L.C.JAMES JRNL TITL DIVERSE HIV VIRUSES ARE TARGETED BY A CONFORMATIONALLY JRNL TITL 2 DYNAMIC ANTIVIRAL. JRNL REF NAT.STRUCT.MOL.BIOL. V. 19 411 2012 JRNL REFN ISSN 1545-9993 JRNL PMID 22407016 JRNL DOI 10.1038/NSMB.2253 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 93.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 41077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2086 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2634 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE SET COUNT : 149 REMARK 3 BIN FREE R VALUE : 0.3340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 272 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.21000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.10000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.381 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.249 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.154 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.683 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6665 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4562 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8963 ; 1.408 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11132 ; 0.872 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 815 ; 6.065 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 279 ;32.366 ;24.373 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1078 ;14.240 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;11.018 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 960 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7454 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1364 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C D E REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 2 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 2 A 67 4 REMARK 3 1 B 2 B 67 4 REMARK 3 1 C 2 C 67 4 REMARK 3 1 D 2 D 67 4 REMARK 3 1 E 2 E 67 4 REMARK 3 2 A 77 A 164 4 REMARK 3 2 B 77 B 164 4 REMARK 3 2 C 77 C 164 4 REMARK 3 2 D 77 D 164 4 REMARK 3 2 E 77 E 164 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2032 ; 0.240 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 B (A): 2032 ; 0.220 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 C (A): 2032 ; 0.280 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 D (A): 2032 ; 0.220 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 E (A): 2032 ; 0.250 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2032 ; 2.220 ; 2.000 REMARK 3 MEDIUM THERMAL 1 B (A**2): 2032 ; 1.770 ; 2.000 REMARK 3 MEDIUM THERMAL 1 C (A**2): 2032 ; 1.120 ; 2.000 REMARK 3 MEDIUM THERMAL 1 D (A**2): 2032 ; 1.600 ; 2.000 REMARK 3 MEDIUM THERMAL 1 E (A**2): 2032 ; 1.600 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 164 REMARK 3 ORIGIN FOR THE GROUP (A): 41.6458 -39.1262 18.0266 REMARK 3 T TENSOR REMARK 3 T11: 0.0305 T22: 0.1875 REMARK 3 T33: 0.0405 T12: -0.0016 REMARK 3 T13: 0.0002 T23: -0.0641 REMARK 3 L TENSOR REMARK 3 L11: 4.1238 L22: 2.9081 REMARK 3 L33: 2.6224 L12: -0.0815 REMARK 3 L13: 0.6841 L23: 1.1090 REMARK 3 S TENSOR REMARK 3 S11: 0.1128 S12: 0.0588 S13: -0.2153 REMARK 3 S21: 0.0255 S22: -0.0916 S23: 0.1491 REMARK 3 S31: 0.0540 S32: -0.1706 S33: -0.0212 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 165 REMARK 3 ORIGIN FOR THE GROUP (A): 22.4251 -50.7583 -7.4794 REMARK 3 T TENSOR REMARK 3 T11: 0.0625 T22: 0.3001 REMARK 3 T33: 0.0802 T12: 0.0125 REMARK 3 T13: -0.0493 T23: -0.0956 REMARK 3 L TENSOR REMARK 3 L11: 3.2010 L22: 2.0822 REMARK 3 L33: 2.9097 L12: -0.0120 REMARK 3 L13: 0.7253 L23: 1.3458 REMARK 3 S TENSOR REMARK 3 S11: 0.0459 S12: -0.0353 S13: 0.0944 REMARK 3 S21: -0.0186 S22: 0.1204 S23: -0.1468 REMARK 3 S31: -0.0269 S32: 0.1651 S33: -0.1663 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 2 C 164 REMARK 3 ORIGIN FOR THE GROUP (A): 38.1511 -4.9311 31.7791 REMARK 3 T TENSOR REMARK 3 T11: 0.3110 T22: 0.1316 REMARK 3 T33: 0.1832 T12: 0.0951 REMARK 3 T13: 0.0483 T23: 0.0014 REMARK 3 L TENSOR REMARK 3 L11: 3.3979 L22: 3.9846 REMARK 3 L33: 2.5722 L12: 0.1405 REMARK 3 L13: 0.2686 L23: 0.3971 REMARK 3 S TENSOR REMARK 3 S11: 0.0300 S12: 0.0321 S13: 0.4353 REMARK 3 S21: 0.0004 S22: -0.0261 S23: 0.4300 REMARK 3 S31: -0.5548 S32: -0.3187 S33: -0.0038 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 2 D 164 REMARK 3 ORIGIN FOR THE GROUP (A): -8.8774 -37.9624 39.8269 REMARK 3 T TENSOR REMARK 3 T11: 0.1152 T22: 0.7046 REMARK 3 T33: 0.4027 T12: 0.0604 REMARK 3 T13: -0.0658 T23: -0.2260 REMARK 3 L TENSOR REMARK 3 L11: 3.1441 L22: 3.9722 REMARK 3 L33: 2.0760 L12: 0.2727 REMARK 3 L13: 0.4323 L23: 1.0867 REMARK 3 S TENSOR REMARK 3 S11: 0.0006 S12: -0.0791 S13: -0.0550 REMARK 3 S21: 0.0485 S22: 0.2422 S23: -0.7427 REMARK 3 S31: 0.0198 S32: 0.6865 S33: -0.2428 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 2 E 164 REMARK 3 ORIGIN FOR THE GROUP (A): -13.4907 -12.4077 15.6746 REMARK 3 T TENSOR REMARK 3 T11: 0.3162 T22: 0.5411 REMARK 3 T33: 0.4219 T12: -0.2301 REMARK 3 T13: 0.2594 T23: -0.1884 REMARK 3 L TENSOR REMARK 3 L11: 3.0205 L22: 3.8837 REMARK 3 L33: 2.9009 L12: 0.2863 REMARK 3 L13: -0.5645 L23: 0.7228 REMARK 3 S TENSOR REMARK 3 S11: 0.1567 S12: 0.0613 S13: 0.2988 REMARK 3 S21: -0.4100 S22: 0.1602 S23: -0.7422 REMARK 3 S31: -0.2798 S32: 0.7328 S33: -0.3169 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 4DGC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070293. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0720 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41285 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 93.938 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.22200 REMARK 200 R SYM FOR SHELL (I) : 0.22200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2WLW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.05 M AMMONIUM SULFATE, 10 MM REMARK 280 MAGNESIUM SULFATE, 0.1 M BIS-TRIS, PH 6.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 141.02000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 282.04000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 211.53000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 352.55000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.51000 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 141.02000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 282.04000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 352.55000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 211.53000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 70.51000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: F, G, H, I, J REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11 REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 CYCLIZATION IS ACHIEVED BY LINKING THE N- AND REMARK 400 THE C- TERMINI. REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: F, G, H, I, J REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 165 REMARK 465 MET B 1 REMARK 465 HIS B 69 REMARK 465 HIS B 70 REMARK 465 ASN B 71 REMARK 465 GLY B 72 REMARK 465 THR B 73 REMARK 465 MET C 1 REMARK 465 HIS C 69 REMARK 465 HIS C 70 REMARK 465 ASN C 71 REMARK 465 GLU C 165 REMARK 465 MET D 1 REMARK 465 HIS D 69 REMARK 465 HIS D 70 REMARK 465 ASN D 71 REMARK 465 GLY D 72 REMARK 465 GLU D 165 REMARK 465 MET E 1 REMARK 465 HIS E 69 REMARK 465 HIS E 70 REMARK 465 ASN E 71 REMARK 465 GLY E 72 REMARK 465 THR E 73 REMARK 465 GLU E 165 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 287 O HOH A 288 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 60 -76.67 -121.44 REMARK 500 ASP A 85 109.55 -57.45 REMARK 500 PHE A 129 -0.32 -144.86 REMARK 500 PHE B 60 -77.50 -129.54 REMARK 500 THR B 119 67.59 -117.25 REMARK 500 PHE C 60 -86.35 -132.82 REMARK 500 THR C 119 64.20 -115.63 REMARK 500 LYS C 133 -61.83 -106.70 REMARK 500 PHE D 60 -79.48 -140.48 REMARK 500 THR D 119 70.99 -119.64 REMARK 500 LYS D 133 -60.23 -96.38 REMARK 500 PHE E 60 -83.91 -128.46 REMARK 500 PHE E 129 -1.50 -143.81 REMARK 500 MVA H 4 77.05 -109.63 REMARK 500 MVA I 4 71.34 -116.10 REMARK 500 MVA J 4 78.31 -114.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN J OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DGA RELATED DB: PDB REMARK 900 TRIMCYP CYCLOPHILIN DOMAIN FROM MACACA MULATTA: HIV-1 CA(O-LOOP) REMARK 900 COMPLEX REMARK 900 RELATED ID: 4DGB RELATED DB: PDB REMARK 900 TRIMCYP CYCLOPHILIN DOMAIN FROM MACACA MULATTA: HIV-2 CA REMARK 900 CYCLOPHILIN-BINDING LOOP COMPLEX REMARK 900 RELATED ID: 4DGD RELATED DB: PDB REMARK 900 TRIMCYP CYCLOPHILIN DOMAIN FROM MACACA MULATTA: H70C MUTANT REMARK 900 RELATED ID: 4DGE RELATED DB: PDB REMARK 900 TRIMCYP CYCLOPHILIN DOMAIN FROM MACACA MULATTA: H70C MUTANT, HIV-1 REMARK 900 CA(O-LOOP) COMPLEX DBREF 4DGC A 1 165 UNP B0LJC8 B0LJC8_MACMU 304 468 DBREF 4DGC B 1 165 UNP B0LJC8 B0LJC8_MACMU 304 468 DBREF 4DGC C 1 165 UNP B0LJC8 B0LJC8_MACMU 304 468 DBREF 4DGC D 1 165 UNP B0LJC8 B0LJC8_MACMU 304 468 DBREF 4DGC E 1 165 UNP B0LJC8 B0LJC8_MACMU 304 468 DBREF 4DGC F 1 11 NOR NOR00033 NOR00033 1 11 DBREF 4DGC G 1 11 NOR NOR00033 NOR00033 1 11 DBREF 4DGC H 1 11 NOR NOR00033 NOR00033 1 11 DBREF 4DGC I 1 11 NOR NOR00033 NOR00033 1 11 DBREF 4DGC J 1 11 NOR NOR00033 NOR00033 1 11 SEQRES 1 A 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 A 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 A 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 A 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 A 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 A 165 ASN PHE THR HIS HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 A 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 A 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 A 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 A 165 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 A 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 A 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 A 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 B 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 B 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 B 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 B 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 B 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 B 165 ASN PHE THR HIS HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 B 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 B 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 B 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 B 165 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 B 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 B 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 B 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 C 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 C 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 C 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 C 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 C 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 C 165 ASN PHE THR HIS HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 C 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 C 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 C 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 C 165 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 C 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 C 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 C 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 D 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 D 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 D 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 D 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 D 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 D 165 ASN PHE THR HIS HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 D 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 D 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 D 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 D 165 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 D 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 D 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 D 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 E 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 E 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 E 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 E 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 E 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 E 165 ASN PHE THR HIS HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 E 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 E 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 E 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 E 165 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 E 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 E 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 E 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 F 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 G 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 H 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 I 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 J 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL F 1 5 HET MLE F 2 9 HET MLE F 3 9 HET MVA F 4 8 HET BMT F 5 13 HET ABA F 6 6 HET SAR F 7 5 HET MLE F 8 9 HET MLE F 10 9 HET DAL G 1 5 HET MLE G 2 9 HET MLE G 3 9 HET MVA G 4 8 HET BMT G 5 13 HET ABA G 6 6 HET SAR G 7 5 HET MLE G 8 9 HET MLE G 10 9 HET DAL H 1 5 HET MLE H 2 9 HET MLE H 3 9 HET MVA H 4 8 HET BMT H 5 13 HET ABA H 6 6 HET SAR H 7 5 HET MLE H 8 9 HET MLE H 10 9 HET DAL I 1 5 HET MLE I 2 9 HET MLE I 3 9 HET MVA I 4 8 HET BMT I 5 13 HET ABA I 6 6 HET SAR I 7 5 HET MLE I 8 9 HET MLE I 10 9 HET DAL J 1 5 HET MLE J 2 9 HET MLE J 3 9 HET MVA J 4 8 HET BMT J 5 13 HET ABA J 6 6 HET SAR J 7 5 HET MLE J 8 9 HET MLE J 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 6 DAL 5(C3 H7 N O2) FORMUL 6 MLE 20(C7 H15 N O2) FORMUL 6 MVA 5(C6 H13 N O2) FORMUL 6 BMT 5(C10 H19 N O3) FORMUL 6 ABA 5(C4 H9 N O2) FORMUL 6 SAR 5(C3 H7 N O2) FORMUL 11 HOH *272(H2 O) HELIX 1 1 VAL A 29 GLY A 42 1 14 HELIX 2 2 THR A 119 ASP A 123 5 5 HELIX 3 3 GLY A 135 ARG A 144 1 10 HELIX 4 4 VAL B 29 GLY B 42 1 14 HELIX 5 5 THR B 119 ASP B 123 5 5 HELIX 6 6 GLY B 135 ARG B 144 1 10 HELIX 7 7 VAL C 29 GLY C 42 1 14 HELIX 8 8 THR C 119 ASP C 123 5 5 HELIX 9 9 GLY C 135 ARG C 144 1 10 HELIX 10 10 VAL D 29 GLY D 42 1 14 HELIX 11 11 THR D 119 ASP D 123 5 5 HELIX 12 12 GLY D 135 ARG D 144 1 10 HELIX 13 13 VAL E 29 GLY E 42 1 14 HELIX 14 14 THR E 119 ASP E 123 5 5 HELIX 15 15 GLY E 135 ARG E 144 1 10 SHEET 1 A 8 PHE A 53 ILE A 57 0 SHEET 2 A 8 MET A 61 GLY A 64 -1 O GLN A 63 N ARG A 55 SHEET 3 A 8 PHE A 112 CYS A 115 -1 O ILE A 114 N CYS A 62 SHEET 4 A 8 ILE A 97 MET A 100 -1 N ILE A 97 O CYS A 115 SHEET 5 A 8 VAL A 128 GLU A 134 -1 O PHE A 129 N LEU A 98 SHEET 6 A 8 GLU A 15 LEU A 24 -1 N SER A 21 O LYS A 133 SHEET 7 A 8 THR A 5 VAL A 12 -1 N ILE A 10 O LEU A 17 SHEET 8 A 8 ILE A 156 GLN A 163 -1 O ASP A 160 N ASP A 9 SHEET 1 B 8 ARG B 55 ILE B 57 0 SHEET 2 B 8 MET B 61 GLY B 64 -1 O GLN B 63 N ARG B 55 SHEET 3 B 8 PHE B 112 CYS B 115 -1 O ILE B 114 N CYS B 62 SHEET 4 B 8 ILE B 97 MET B 100 -1 N SER B 99 O PHE B 113 SHEET 5 B 8 VAL B 128 GLU B 134 -1 O GLY B 130 N LEU B 98 SHEET 6 B 8 GLU B 15 LEU B 24 -1 N SER B 21 O LYS B 133 SHEET 7 B 8 THR B 5 VAL B 12 -1 N VAL B 12 O GLU B 15 SHEET 8 B 8 ILE B 156 GLN B 163 -1 O ASP B 160 N ASP B 9 SHEET 1 C 8 ARG C 55 ILE C 57 0 SHEET 2 C 8 MET C 61 GLY C 64 -1 O GLN C 63 N ARG C 55 SHEET 3 C 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62 SHEET 4 C 8 ILE C 97 MET C 100 -1 N ILE C 97 O CYS C 115 SHEET 5 C 8 VAL C 128 GLU C 134 -1 O GLY C 130 N LEU C 98 SHEET 6 C 8 GLU C 15 LEU C 24 -1 N SER C 21 O LYS C 133 SHEET 7 C 8 THR C 5 VAL C 12 -1 N VAL C 12 O GLU C 15 SHEET 8 C 8 ILE C 156 GLN C 163 -1 O ASP C 160 N ASP C 9 SHEET 1 D 8 ARG D 55 ILE D 57 0 SHEET 2 D 8 MET D 61 GLY D 64 -1 O GLN D 63 N ARG D 55 SHEET 3 D 8 PHE D 112 CYS D 115 -1 O ILE D 114 N CYS D 62 SHEET 4 D 8 ILE D 97 MET D 100 -1 N ILE D 97 O CYS D 115 SHEET 5 D 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98 SHEET 6 D 8 GLU D 15 LEU D 24 -1 N SER D 21 O LYS D 133 SHEET 7 D 8 THR D 5 VAL D 12 -1 N PHE D 8 O VAL D 20 SHEET 8 D 8 ILE D 156 GLN D 163 -1 O ASP D 160 N ASP D 9 SHEET 1 E 8 ARG E 55 ILE E 57 0 SHEET 2 E 8 MET E 61 GLY E 64 -1 O GLN E 63 N ARG E 55 SHEET 3 E 8 PHE E 112 CYS E 115 -1 O ILE E 114 N CYS E 62 SHEET 4 E 8 ILE E 97 MET E 100 -1 N ILE E 97 O CYS E 115 SHEET 5 E 8 VAL E 128 GLU E 134 -1 O GLY E 130 N LEU E 98 SHEET 6 E 8 GLU E 15 LEU E 24 -1 N SER E 21 O LYS E 133 SHEET 7 E 8 THR E 5 VAL E 12 -1 N VAL E 12 O GLU E 15 SHEET 8 E 8 ILE E 156 GLN E 163 -1 O ASP E 160 N ASP E 9 LINK C DAL F 1 N MLE F 2 1555 1555 1.34 LINK N DAL F 1 C ALA F 11 1555 1555 1.33 LINK C MLE F 2 N MLE F 3 1555 1555 1.34 LINK C MLE F 3 N MVA F 4 1555 1555 1.35 LINK C MVA F 4 N BMT F 5 1555 1555 1.33 LINK C BMT F 5 N ABA F 6 1555 1555 1.32 LINK C ABA F 6 N SAR F 7 1555 1555 1.34 LINK C SAR F 7 N MLE F 8 1555 1555 1.32 LINK C MLE F 8 N VAL F 9 1555 1555 1.33 LINK C VAL F 9 N MLE F 10 1555 1555 1.34 LINK C MLE F 10 N ALA F 11 1555 1555 1.34 LINK C DAL G 1 N MLE G 2 1555 1555 1.33 LINK N DAL G 1 C ALA G 11 1555 1555 1.31 LINK C MLE G 2 N MLE G 3 1555 1555 1.34 LINK C MLE G 3 N MVA G 4 1555 1555 1.34 LINK C MVA G 4 N BMT G 5 1555 1555 1.32 LINK C BMT G 5 N ABA G 6 1555 1555 1.33 LINK C ABA G 6 N SAR G 7 1555 1555 1.33 LINK C SAR G 7 N MLE G 8 1555 1555 1.34 LINK C MLE G 8 N VAL G 9 1555 1555 1.33 LINK C VAL G 9 N MLE G 10 1555 1555 1.33 LINK C MLE G 10 N ALA G 11 1555 1555 1.33 LINK C DAL H 1 N MLE H 2 1555 1555 1.35 LINK N DAL H 1 C ALA H 11 1555 1555 1.34 LINK C MLE H 2 N MLE H 3 1555 1555 1.35 LINK C MLE H 3 N MVA H 4 1555 1555 1.34 LINK C MVA H 4 N BMT H 5 1555 1555 1.35 LINK C BMT H 5 N ABA H 6 1555 1555 1.33 LINK C ABA H 6 N SAR H 7 1555 1555 1.34 LINK C SAR H 7 N MLE H 8 1555 1555 1.34 LINK C MLE H 8 N VAL H 9 1555 1555 1.34 LINK C VAL H 9 N MLE H 10 1555 1555 1.34 LINK C MLE H 10 N ALA H 11 1555 1555 1.33 LINK C DAL I 1 N MLE I 2 1555 1555 1.34 LINK N DAL I 1 C ALA I 11 1555 1555 1.33 LINK C MLE I 2 N MLE I 3 1555 1555 1.35 LINK C MLE I 3 N MVA I 4 1555 1555 1.34 LINK C MVA I 4 N BMT I 5 1555 1555 1.33 LINK C BMT I 5 N ABA I 6 1555 1555 1.33 LINK C ABA I 6 N SAR I 7 1555 1555 1.33 LINK C SAR I 7 N MLE I 8 1555 1555 1.34 LINK C MLE I 8 N VAL I 9 1555 1555 1.34 LINK C VAL I 9 N MLE I 10 1555 1555 1.33 LINK C MLE I 10 N ALA I 11 1555 1555 1.33 LINK C DAL J 1 N MLE J 2 1555 1555 1.34 LINK N DAL J 1 C ALA J 11 1555 1555 1.33 LINK C MLE J 2 N MLE J 3 1555 1555 1.34 LINK C MLE J 3 N MVA J 4 1555 1555 1.35 LINK C MVA J 4 N BMT J 5 1555 1555 1.34 LINK C BMT J 5 N ABA J 6 1555 1555 1.32 LINK C ABA J 6 N SAR J 7 1555 1555 1.34 LINK C SAR J 7 N MLE J 8 1555 1555 1.34 LINK C MLE J 8 N VAL J 9 1555 1555 1.33 LINK C VAL J 9 N MLE J 10 1555 1555 1.33 LINK C MLE J 10 N ALA J 11 1555 1555 1.33 SITE 1 AC1 17 ARG A 55 PHE A 60 GLN A 63 ASN A 71 SITE 2 AC1 17 GLY A 72 THR A 73 GLU A 81 ALA A 101 SITE 3 AC1 17 ASN A 102 ALA A 103 GLN A 111 PHE A 113 SITE 4 AC1 17 TRP A 121 HIS A 126 LYS C 31 TYR C 79 SITE 5 AC1 17 HOH F 101 SITE 1 AC2 21 PRO A 30 TYR A 79 ARG B 55 PHE B 60 SITE 2 AC2 21 GLN B 63 ALA B 101 ASN B 102 ALA B 103 SITE 3 AC2 21 GLN B 111 PHE B 113 TRP B 121 HIS B 126 SITE 4 AC2 21 GLY C 72 THR C 73 GLU C 81 ALA C 103 SITE 5 AC2 21 HOH G 101 HOH G 102 ABA H 6 SAR H 7 SITE 6 AC2 21 MLE H 8 SITE 1 AC3 19 GLY B 74 GLU B 81 ALA B 103 ARG C 55 SITE 2 AC3 19 PHE C 60 GLN C 63 ALA C 101 ASN C 102 SITE 3 AC3 19 ALA C 103 GLN C 111 PHE C 113 TRP C 121 SITE 4 AC3 19 HIS C 126 LYS D 31 TYR D 79 ABA G 6 SITE 5 AC3 19 SAR G 7 MLE G 8 HOH H 101 SITE 1 AC4 18 ARG D 55 PHE D 60 GLN D 63 ALA D 101 SITE 2 AC4 18 ASN D 102 ALA D 103 GLN D 111 PHE D 113 SITE 3 AC4 18 TRP D 121 HIS D 126 PRO E 30 LYS E 31 SITE 4 AC4 18 TYR E 79 GLU E 81 ALA E 103 ABA J 6 SITE 5 AC4 18 SAR J 7 MLE J 8 SITE 1 AC5 16 LYS B 31 TYR B 79 THR D 73 GLU D 81 SITE 2 AC5 16 ARG E 55 PHE E 60 GLN E 63 ALA E 101 SITE 3 AC5 16 ASN E 102 GLN E 111 PHE E 113 TRP E 121 SITE 4 AC5 16 HIS E 126 ABA I 6 SAR I 7 MLE I 8 CRYST1 108.470 108.470 423.060 90.00 90.00 120.00 P 61 2 2 60 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009219 0.005323 0.000000 0.00000 SCALE2 0.000000 0.010645 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002364 0.00000